...

首页> 外文期刊>Annals of oncology: official journal of the European Society for Medical Oncology >Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial (vol 28, pg 128, 2017)

【24h】

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial (vol 28, pg 128, 2017)

机译：途径水平改变而不是单一基因的突变预测对Neo-Altto试验中的Her2针对性疗法（第28卷，PG 128,2017）的反应

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Annals of oncology: official journal of the European Society for Medical Oncology》 |2019年第6期|共1页
作者
Shi W.; Jiang T.; Nuciforo P.; Hatzis C.; Holmes E.; Harbeck N.; Sotiriou C.; Pena L.; Loi S.; Rosa D. D.; Chia S.; Wardley A.; Ueno T.; Rossari J.; Eidtmann H.; Armour A.; Piccart-Gebhart M.; Rimm D. L.; Baselga J.; Pusztai L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
专利

1. Baseline Hepatitis B Virus DNA Level is a Promising Factor for Predicting the 3rd Month Virological Response to Entecavir Therapy: A Study of Strict Defined Hepatitis B virus Induced Cirrhosis [J] . Yang Xu, Xiao-Ning Wu, Yi-Wen Shi, 中华医学杂志（英文版） . 2015,第014期
2. Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients [J] . Mahmoud A Khattab, Hend M Abdelghany, Maggie M Ramzy, 生物医学研究杂志（英文版） . 2016,第001期
3. Impact of IL28B gene polymorphisms rs8099917 and rs12980275 on response to pegylated interferon-α/ribavirin therapy in chronic hepatitis C genotype 4 patients [J] . Mahmoud A Khattab, Hend M Abdelghany, Maggie M Ramzy, 生物医学研究杂志：英文版 . 2016,第001期
4. Gene polymorphisms of interleukin-28, p21-activated protein kinases 4, and response to interferon-α based therapy in Chinese patients with chronic hepatitis B [J] . YU Feng-xue, ZHANG Xiao-lin, WANG Yan-ping, 中华医学杂志（英文版） . 2013,第009期
5. Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial (vol 28, pg 128, 2017) [J] . Shi W., Jiang T., Nuciforo P., Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第10期

机译：途径水平改变而不是单一基因的突变预测对Neo-Altto试验中的Her2针对性疗法（第28卷，PG 128,2017）的反应
6. Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial (vol 28, pg 128, 2017) [J] . Shi W., Jiang T., Nuciforo P., Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第4期

机译：途径水平改变而不是单一基因的突变预测对Neo-Altto试验中的Her2针对性疗法（第28卷，PG 128,2017）的反应
7. Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies [J] . Sinead Toomey, Alexander J. Eustace, Joanna Fay, Breast Cancer Research . 2017,第1期

机译：体细胞PI3K途径和ERBB家族突变对接受新辅助HER2靶向治疗的HER2阳性乳腺癌患者的病理完全缓解（pCR）的影响
8. rSNP_Guide: Meta-Tools Predicting of Regulatory DNA Signals Damaged/Appeared Due to Single Nucleotide Mutation by Alterations in Pattern of DNA Binding to Nuclear Proteins [C] . Mikhail Ponomarenko, Tatyana Merkulova, Julia Ponomarenko, International NAISO(Natural amp; Artificial Intelligence Systems Organization) Congress on Information Science Innovations Mar 17-21, 2001 Dubai, U.A.E. . 2001

机译：rSNP_Guide：预测由于单核苷酸突变导致DNA结合核蛋白模式改变而破坏/显示的调控DNA信号的元工具
9. Biomarkers for Predicting Response to HER2-targeted Therapies [D] . Lee, Pei Rong Evelyn. 2018

机译：用于预测对HER2目标疗法的反应的生物标志物
10. Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial [O] . W Shi, T Jiang, P Nuciforo, -1

机译：在新ALTTO试验中通路水平的改变而非单个基因的突变预测了针对HER2靶向疗法的反应
11. correction to: Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial [O] . W. Shi, T. Jiang, P. Nuciforo, 2018

机译：校正：途径水平改变而不是单一基因的突变预测对Neo-Altto试验中的Her2目标疗法的反应

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号